Mortimer Ian's Form 4 filing
Xenon Pharmaceuticals Inc. (XENE) · filed May 26, 2023
- Accession no.
- 0000950170-23-024600
- Filed
- May 26, 2023
- Trade date
- May 24, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 9 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.31M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mortimer IanCIK 0001619961 | Director, Officer (PRESIDENT & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 24, 2023 | Common Shares | MOption exerciseAcquired | +42,592 | $9.44 | +$402,068.48 | 48,592 | Direct | |
| May 24, 2023 | Common Shares | FTax withholdingDisposed | −7,310 | $41.84 | −$305,850.4 | 41,282 | Direct | |
| May 24, 2023 | Common Shares | SSaleDisposed | −17,069 | $41.44 | −$707,339.36 | 24,213 | Direct | |
| May 24, 2023 | Common Shares | MOption exerciseAcquired | +20,576 | $9.85 | +$202,673.6 | 44,789 | Direct | |
| May 24, 2023 | Common Shares | FTax withholdingDisposed | −3,902 | $41.84 | −$163,259.68 | 40,887 | Direct | |
| May 24, 2023 | Common Shares | SSaleDisposed | −13,179 | $41.37 | −$545,215.23 | 27,708 | Direct | |
| May 24, 2023 | Common Shares | MOption exerciseAcquired | +6,172 | $9.85 | +$60,794.2 | 33,880 | Direct | |
| May 24, 2023 | Common Shares | FTax withholdingDisposed | −1,171 | $41.84 | −$48,994.64 | 32,709 | Direct | |
| May 24, 2023 | Common Shares | SSaleDisposed | −1,407 | $41.49 | −$58,376.43 | 31,302 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 24, 2023 | Common Shares | MOption exerciseDisposed | −42,592 | $0.00 | $0 | 0 | Direct | |
| May 24, 2023 | Common Shares | MOption exerciseDisposed | −20,576 | $0.00 | $0 | 0 | Direct | |
| May 24, 2023 | Common Shares | MOption exerciseDisposed | −6,172 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.